Scientists hunt for pancreatic cancer signs in waste fluid
NCT ID NCT04370574
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks for new ways to diagnose pancreatic cancer, a disease that is often caught too late. Researchers will analyze fluid that is normally thrown away after a standard biopsy procedure. They hope to find proteins or other molecules that could lead to a simple blood test for earlier detection. The study involves 200 people with a suspicious pancreatic mass who are already scheduled for a biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to detect pancreatic cancer earlier, potentially improving survival rates.
- What could go wrong
- This is an early discovery study, not a treatment trial. The identified biomarkers may not prove accurate enough for clinical use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uh Montpellier
RECRUITINGMontpellier, Montpellier, 34280, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- A sound wave that could expose hidden pancreatic cancer?